Gwyneth Paltrow calls peptides one of her biggest wellness tools. Joe Rogan credits one with healing an old injury. Hailey Bieber built a skincare line around them. Most have cleared only animal trials, not human ones. This week, Bengaluru gave the trend its own fifty-person, invite-only guest list.
That, combined with a six-course menu the poster describes as "all oral, research grade," is the pitch behind India's first 'Peptide Party', scheduled in Bengaluru for August 29. Peptide enthusiast Anushka Singh announced it on X, hosting alongside the peptide brand Peptide OS and peer Nakshatraa Pingale. The fifty seats filled fast enough that within a day, organisers were fielding upward of two hundred registrations and hunting for a bigger room.
Sowmay Jain, founder of Upsurge Labs, where Pingale and Singh work, and of Zelta Health, described months on a personal stack in a longer post, crediting it with healing a years-old back problem and testing his biological age two and a half years younger. He argued India needs a regulatory body rather than doctors dismissing an entire class of molecules outright.
Why an Invite Like This Doesn't Feel Strange Anymore
Bengaluru didn't invent any of this. Peptides have spent the past year working their way out of bodybuilding forums and into group chats, and a glance at who's already talking about them explains why an invite themed around syringes doesn't strike its recipients as strange. Gwyneth Paltrow calling peptide shots one of her biggest wellness tools, Joe Rogan saying BPC-157 with healing an old injury, and UFC heavyweight Derrick Lewis telling a podcast in January that the UFC itself "provided me with some great peptides," all add up.
Jennifer Aniston, Kendall Jenner, Hailey Bieber are also some of the names that have hyped up peptides in the public domain. Even America's health secretary counts himself a fan. Robert F Kennedy Jr has described himself as an enthusiast on Joe Rogan's own podcast and pushed to loosen FDA restrictions on several peptides, while Gary Brecka, who calls himself the Ultimate Human and has hosted Kennedy on his own podcast, promotes a protocol built around sermorelin paired with CJC-1295 and ipamorelin.
In July, the FDA's Pharmacy Compounding Advisory Committee spent two days reviewing seven peptides for a list that determines what specialty pharmacies are legally allowed to make, and voted, narrowly, to recommend six of them: BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax. Only one, a sleep peptide called DSIP, was rejected. In dossiers submitted ahead of the meeting, they wrote that there was too little evidence to call any of the seven peptides either safe or effective.
Elizabeth Rebello, an anaesthesiologist at MD Anderson Cancer Center who cast one of the no votes, told reporters she was concerned the committee was "responding to a market-induced demand rather than a decision based in solid science." The vote isn't binding, and the peptides still have to clear a formal rulemaking process, but the FDA typically follows its advisory committees' recommendations, and many of the members who voted yes have consulted for or worked at companies that stand to profit if it does.
So, What Are Peptides Actually
Peptides themselves are short chains of amino acids the body already produces, signalling cells to repair tissue or regulate hormones. Insulin counts as one. So do the GLP-1 drugs behind the Ozempic wave, semaglutide and tirzepatide, both approved after years of clinical trials.
A review published in the journal Signal Transduction and Targeted Therapy puts the count at more than 80 peptide drugs reaching the market worldwide since insulin's discovery in 1921, with 33 of those non-insulin peptides approved since the year 2000 alone. The peptides driving parties and Instagram captions belong to a different category entirely; names with no regulatory approval anywhere, sold through what researchers call the grey market, usually labelled "for research purposes only."
The Evidence Gap
Dr Pieter Cohen, quoted in Harvard Medical School's own publication Harvard Health, has a stoic read on where the evidence for that second group actually stands. The claims attached to grey market peptides haven't been vetted by the FDA or any expert body, and mostly run ahead of the data. His advice to patients is direct, he does not recommend injecting yourself with peptides.
Stuart Phillips, who holds a Canada Research Chair in Skeletal Muscle Health at McMaster University, went looking for the human evidence behind BPC-157 in a piece written for The Conversation. He found almost nothing standing under it. A 2025 systematic review he cites screened 544 papers on the compound and found only 36 that met basic inclusion criteria, 35 of those in rodents or cells. Only one involved humans in a musculoskeletal context, a case series covering 16 patients.
Add a small pilot on interstitial cystitis with 12 women and a safety trial that ran on two healthy adults, and that's the entire published human evidence base for one of the most hyped molecules in the category. Topol has flagged a sharper worry on the safety side: TB-500 accelerated dormant tumour growth in animal studies, and the growth hormone peptides in Brecka's own stack carry a theoretical cancer risk simply because they work by inducing broad cell growth.
ALSO READ: Indian Startup Leans On Cancer-Sniffing Dogs And AI For Early Detection
What's Actually in the Vial
Contamination is the worry once the vials arrive. A 2024 study published in the Journal of Medical Internet Research test purchased semaglutide from illegal online pharmacies and ran laboratory analysis on what came back. Purity measured between 8-14% against a 99% claim on the label. Every sample tested positive for endotoxin. None of this is BPC-157 specifically, but it's the same grey market, the same manufacturing conditions, and the same absence of anyone checking what's actually in the vial before it reaches a person.
Looksmaxxing: Biohacking's Younger, Angrier Cousin
Peptides sit inside a wider habit called biohacking, broadly defined as using technology, supplements and lifestyle changes to optimise the body outside a doctor's office. Most of that world looks like sleep trackers and cold plunges. A specific offshoot called looksmaxxing looks very different, and the peptide industry has slowly become part of it.
The term itself didn't start as a wellness trend. It was coined on incel message boards in the 2010s, three now-defunct forums that ran their own attractiveness rating system, and it carried an ideology called the black pill, the belief that attraction runs almost entirely on fixed physical traits rather than anything a person can control. The word jumped to mainstream TikTok in the early 2020s, at first with more self-deprecating humour attached, and its darker roots have followed it into the mainstream since.
Practitioners split the practice into two tiers. Softmaxxing covers the harmless end, skincare and gym routines repackaged from old GQ columns. Hardmaxxing is where peptides live, alongside anabolic steroids and unauthorised growth hormone, aimed at a sharper jawline and a set of downward-tilted eyes the community calls hunter eyes.
The Wall Street Journal has reported on how young this crowd is getting. One case in its reporting involved an 18-year-old high school senior in the Bay Area whose friend introduced him to Melanotan II, a tanning peptide, and suggested they try it together. Adda Grimberg, a paediatric endocrinologist and scientific director of the Growth Center at Children's Hospital of Philadelphia, warned that in people whose growth plates haven't closed, growth hormone peptides can cause disproportionate growth in the hands, feet, jaw and tongue, and that uncontrolled cell growth is, in her words, "essentially cancer."
ALSO READ: Economics Of Met Gala: Do Fashion And Art Need The Tech Bros To Stay Afloat?
The Backlash
This is the layer of context sitting behind the fight Bengaluru's hosts have found themselves in. Dr Cyriac Abby Philips, the Kochi based hepatologist, known on X as The Liver Doc, quote-tweeted Singh's announcement with this line: "Health influencers driven peptides market and promos are the Sadhguru of the pseudoscience and fringe science world." He argued that evidence which needs a party instead of peer review probably isn't evidence, just a reason to throw one. Philips isn't new to this kind of fight. A Bengaluru court briefly got X to suspend his account in 2023 after Himalaya Wellness sued him over tweets criticising its supplements, an order a higher court later unwound.
Krish Ashok, the software engineer turned food science writer behind the bestselling book Masala Lab, weighed in separately on X, and his critique ran more clinical than Philips's. Unless the peptide in question is insulin, semaglutide or another properly tested medicine, he wrote, buying into the trend means paying to join an uncontrolled clinical trial with an N of one. Most candidate molecules, he added, never survive that stage at all.
San Francisco Got There First
Bengaluru isn't the first city to throw this particular kind of party this year. The San Francisco Standard has reported on a twenty four year old named Julius Ritter who runs something called the California Peptide Club out of AGI House, a Twin Peaks mansion where AI founders rent rooms to work.
Business Insider covered the inaugural gathering back in April, which drew more than a hundred people and left another three hundred on a waitlist, something Ritter said he hoped to turn into a monthly ritual, and has since kept going as a recurring event he promotes as Pep Talks and Afterpepty. Ritter's own recap of the launch, posted on X, describes an injection tutorial performed on stage, and says that when he asked the room who was on peptides, nearly every hand went up. Asked who specifically was on research-use-only product, every hand stayed up.
Ritter's own peptide journey started the way Sowmay Jain's did, a blood test showing his testosterone in the bottom one percent for his age, followed by a stack he now swears by. Doctors pushed back there too. Jordan Shlain, who runs a concierge practice called Private Medical, told the San Francisco Standard there's no transparency or intellectual honesty in how the products are sourced, and called the whole scene "just theater." He warned some of the immune reactions these compounds can trigger could be irreversible.
Is Any of This Legal?
Underneath the social media back-and-forth sits a regulatory question. India has no separate legal category for peptides. Anything meant to treat, prevent or alter a bodily function falls under the Drugs and Cosmetics Act, 1940, policed nationally by the Central Drugs Standard Control Organisation and, in Karnataka, by the state's Food Safety and Drug Administration. Approved peptides sit in Schedule H, sold only against a prescription. BPC-157, TB-500 and the rest of the hyped peptides carry no Indian marketing approval at all.
Personal-use import has a narrow legal route under Rule 36, small quantities, declared at customs, strictly for the importer's own use. Karnataka's health department filed twenty nine legal cases under the Act in July alone and issued show-cause notices to two hundred thirty one pharmacies for selling prescription drugs without one. CDSCO has run a parallel nationwide drive specifically targeting GLP-1 peptide sales after the Delhi High Court flagged unregulated Ozempic use and asked the regulator to respond. Nobody official has said anything about the Bangalore party specifically.
Paltrow once made Shallow Hal, a film about the gap between how you look and what's actually good for you. Aniston made Office Space, about escaping the daily grind. Bengaluru's peptide crowd is chasing a version of both, a shortcut to feeling younger and healed, minus the slow, unglamorous work of proving any of it is safe.
ALSO READ: Weight Loss Drugs Boom: Wellness Platforms Advertise Treatment Plans, But Is It Legal?
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
